Skip to main content

Table 3 Meta-analysis of the association of HSD17B13 rs72613567: TA allelic variant and liver disease susceptibility

From: Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis

Liver disease

Number of studies

Relevance test

Heterogeneity test

Publication

OR(95% CI)

 

Z

Pvalue

I2

Q

Phel

Pegger

HCC compared with CLD (allelic model)

5

0.766(0.682–0.860)

4.51

0.000

45.8

7.38

0.117

0.378

1.03

HCC compared with CLD (additive model)

3

0.755(0.645–0.885)

3.47

0.001

0

1.91

0.384

0.845

-0.25

HCC compared with healthy controls (allelic model)

3

0.648(0.429–0.979)

2.06

0.039

62.1

5.28

0.071

0.033

19.01

NAFLD compared with NON-NAFLD (allelic model)

5

0.669(0.524–0.856)

3.20

0.001

68.9

12.87

0.012

0.280

0.800

NAFLD compared with healthy controls (allelic model)

3

0.600(0.464–0.777)

3.89

0.000

50.3

4.02

0.134

0.060

0.963